SPX5,638.94+117.42 2.13%
DIA415.36+6.58 1.61%
IXIC17,754.09+451.07 2.61%

RBC Capital Maintains Outperform on QuidelOrtho, Lowers Price Target to $61

Benzinga·02/13/2025 16:57:16
Listen to the news
RBC Capital analyst Conor McNamara maintains QuidelOrtho (NASDAQ:QDEL) with a Outperform and lowers the price target from $64 to $61.